Page 208 - Read Online

Bilovol et al. Relationship between atrial fibrillation, BMI and adipokines

DECLARATIONS JAMA 2004;292:2471-7.
8. Guglin M, Maradia K, Chen R, Curtis AB. Relation of obesity
to recurrence rate and burden of atrial fibrillation. Am J Cardiol
Authors’ contributions 2011;107:579-82.
Study design: O. Bilovol, I. Ilchenko 9. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk
Development of methodology: O. Bilovol factors for atrial fibrillation or flutter: the Danish diet, cancer, and
Collection of data: O. Bilovol, Y. Shaposhnikova, I. health study. Am J Med 2005;118:489-95.
Ilchenko, A. Shalimova 10. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ.
Analysis and/or interpretation of data: O. Bilovol, Y. Long-term cardiovascular consequences of obesity: 20-year follow-
up of more than 15 000 middle-aged men and women (the Renfrew-
Shaposhnikova, I. Ilchenko, A. Shalimova Paisley study). Eur Heart J 2006;27:96-106.
Writing (not revising) all or sections of the manuscript: 11. Goette A, Staack T, Röcken C, Arndt M, Geller JC, Huth C, Ansorge
O. Bilovol, Y. Shaposhnikova, I. Ilchenko, A. Shalimova S, Klein HU, Lendeckel U. Increased expression of extracellular
Manuscript review: O. Bilovol, I. Ilchenko signal-regulated kinase and angiotensin-converting enzyme in human
Supervision: O. Bilovol atria during atrial fibrillation. J Am Coll Cardiol 2000;35:1669-77.
12. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in
Financial support and sponsorship patients with atrial fibrillation: mechanisms and clinical implications.
J Am Coll Cardiol 2015;66:943-59.
None. 13. Nattel S, Harada M. Atrial remodeling and atrial fibrillation:
recent advances and translational perspectives. J Am Coll Cardiol
Conflicts of interest 2014;63:2335-45.
There are no conflicts of interest. 14. Ito K, Date T, Kawai M, Nojiri A, Narui R, Hioki M, Tanigawa S,
Yamashita S, Tokuda M, Inada K, Matsuo S, Yamane T, Yoshimura
Patient consent M. Morphological change of left atrium in obese individuals. Int J
Cardiol 2011;152:117-9.
Each patient was informed the study and gave their 15. Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug BA,
consent. Asirvatham SJ, Shen WK, Lee HC, Bielinski SJ, Hodge DO, Herges
RM, Buescher TL, Wu JH, Ma C, Zhang Y, Chen PS, Packer DL,
Ethics approval Cha YM. Electrophysiological and hemodynamic characteristics
The study protocol was supported by the Ethics associated with obesity in patients with atrial fibrillation. J Am Coll
Committee of the Kharkiv National Medical University. Cardiol 2012;60:851-60.
16. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation
and metabolic disease. Nat Rev Immunol 2011;11:85-97.
REFERENCES 17. Van de Voorde J, Pauwels B, Boydens C, Decaluwé K. Adipocytokines
in relation to cardiovascular disease. Metabolism 2013;62:1513-21.
1. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. 18. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S,
Circ Res 2016;118:1752-70. Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk
2. Asghar O, Alam U, Hayat SA, Aghamohammadzadeh R, Heagerty factor clustering and the normal weight with cardiometabolic risk factor
AM, Malik RA. Obesity, diabetes and atrial fibrillation; epidemiology, clustering: prevalence and correlates of 2 phenotypes among the US
mechanisms and interventions. Curr Cardiol Rev 2012;8:253-64. population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-24.
3. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all- 19. Macheret F, Bartz TM, Djousse L, Ix JH, Mukamal KJ, Zieman SJ,
cause mortality with overweight and obesity using standard body Siscovick DS, Tracy RP, Heckbert SR, Psaty BM, Kizer JR. Higher
mass index categories: a systematic review and meta-analysis. JAMA circulating adiponectin levels are associated with increased risk of
2013;309:71-82. atrial fibrillation in older adults. Heart 2015;101:1368-74.
4. Lee H, Choi EK, Lee SH, Han KD, Rhee TM, Park CS, Lee SR, Choe 20. Jung UJ, Choi MS. Obesity and its metabolic complications: the role
WS, Lim WH, Kang SH, Cha MJ, Oh S. Atrial fibrillation risk in of adipokines and the relationship between obesity, inflammation,
metabolically healthy obesity: a nationwide population-based study. insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
Int J Cardiol 2017;240:221-7. Int J Mol Sci 2014;15:6184-223.
5. Payvar S, Kim S, Rao SV, Krone R, Neely M, Paladugu N, Daggubati 21. Kizer JR, Benkeser D, Arnold AM, Djousse L, Zieman SJ, Mukamal
R. In-hospital outcomes of percutaneous coronary interventions KJ, Tracy RP, Mantzoros CS, Siscovick DS, Gottdiener JS, Ix JH.
in extremely obese and normal-weight patients: findings from the Total and high-molecular-weight adiponectin and risk of coronary
NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol heart disease and ischemic stroke in older adults. J Clin Endocrinol
2013;62:692-6. Metab 2013;98:255-63.
6. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, 22. Anan M, Uchihashi K, Aoki S, Matsunobu A, Ootani A, Node K, Toda
Steinberg JS. Atrial fibrillation and obesity--results of a meta-analysis. S. A promising culture model for analyzing the interaction between
Am Heart J 2008;155:310-5. adipose tissue and cardiomyocytes. Endocrinology 2011;152:1599-605.
7. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, 23. Colwell JA. Type 2 diabetes, pre-diabetes, and the metabolic
Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. syndrome. JAMA 2011;306:215.

Vessel Plus ¦ Volume 1 ¦ December 28, 2017 201